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Cardiac (myo)fibroblasts modulate 
the migration of monocyte subsets
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Carsten Tschöpe1,2,3 & Sophie Van Linthout1,2,3
Cardiac fibroblasts play an important role in the regulation of the extracellular matrix and are newly 
recognized as inflammatory supporter cells. Interferon (IFN)-γ is known to counteract transforming 
growth factor (TGF)-ß1-induced myofibroblast differentiation. This study aims at investigating in vitro 
how IFN-γ affects TGF-ß1-induced monocyte attraction. Therefore, C4 fibroblasts and fibroblasts 
obtained by outgrowth culture from the left ventricle (LV) of male C57BL6/j mice were stimulated with 
TGF-β1, IFN-γ and TGF-β1 + IFN-γ. Confirming previous studies, IFN-γ decreased the TGF-ß1-induced 
myofibroblast differentiation, as obviated by lower collagen I, III, α-smooth muscle actin (α-SMA), 
lysyl oxidase (Lox)-1 and lysyl oxidase-like (LoxL)-2 levels in TGF-β1 + IFN-γ- versus TGF-ß1-stimulated 
cardiac fibroblasts. TGF-β1 + IFN-γ-stimulated C4 and cardiac fibroblasts displayed a higher CC-
chemokine ligand (CCL) 2, CCL7 and chemokine C-X3-C motif ligand (Cx3CL1) release versus sole TGF-
ß1-stimulated fibroblasts. Analysis of migrated monocyte subsets towards the different conditioned 
media further revealed that sole TGF-β1- and IFN-γ-conditioned media particularly attracted Ly6Clow 
and Ly6Chigh monocytes, respectively, as compared to control media. In line with theses findings, TGF-
β1 + IFN-γ-conditioned media led to a lower Ly6Clow/Ly6Chigh monocyte migration ratio compared to 
sole TGF-ß1 treatment. These differences in monocyte migration reflect the complex interplay of pro-
inflammatory cytokines and pro-fibrotic factors in cardiac remodelling and inflammation.
Cardiac fibroblasts are centrally involved in myocardial remodelling1. While their main role is traditionally 
believed to be the regulation of the extracellular matrix proteins, their function as inflammatory supporter cells 
has attracted recognition2,3. During the development of heart failure, the immune system is activated locally in the 
myocardium as well as systemically. The following interaction of the different cellular and humoral components 
of the immune system with the cardiac innate cells orchestrates the myocardial remodelling and compensatory 
mechanisms4. There is currently a growing body of evidence that the immune system exhibits significant effects 
on cardiac fibroblasts by controlling their activation and transformation into myofibroblasts3,5.
TGF-β1, secreted by immune cells, cardiac fibroblasts and cardiomyocytes6, induces myofibroblast transdif-
ferentiation and matrix deposition, characterized by the enhancement of collagen I, collagen III and α-SMA, and 
it is involved in cell proliferation, endothelial-to-mesenchymal transition7, immune suppression and inflamma-
tion8. Maintenance of the extracellular matrix and myofibroblast persistence is essential to preserve functional 
cardiac integrity after ischemic injury9. IFN-γ is the key cytokine in the Th1 reaction and is produced in large 
amounts by different cell types, mainly CD4+ helper T cells, CD8+ cytotoxic T cells and natural killer (NK) 
cells10. In a previous study, we demonstrated that increased levels of IFN-γ and an excessive Th1 reaction after 
myocardial infarction leads to decreased myofibroblast differentiation with detrimental effects in scar formation 
and myocardial remodelling11. This supports the general consensus that an extended or prolonged inflammation 
results in inadequate myocardial wound healing and scar formation associated with a suppression of systolic 
function and chamber dilation12.
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, 
and Berlin Institute of Health, Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Berlin, 
Germany. 2DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany. 3Charité – 
Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and 
Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies, Campus Virchow Klinikum, Berlin, 
Germany. 4Inherited Cardiovascular Diseases Unit, Barts Health NHS Trust, Barts Heart Centre, London, UK. 5William 
Harvey Research Institute, Queen Mary University London, London, UK. 6Department of Biomedical Sciences, 
Humanitas University; Adaptive Immunity Laboratory, Humanitas Clinical and Research Center Pieve Building, 
Rozzano, Milano, Italy. Carsten Tschöpe and Sophie Van Linthout contributed equally to this work. Correspondence 
and requests for materials should be addressed to S.V.L. (email: sophie.van-linthout@charite.de)
Received: 14 November 2017
Accepted: 8 March 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIeNTIFIC RepoRts |  (2018) 8:5575  | DOI:10.1038/s41598-018-23881-7
Besides T and NK cells, monocytes also play a pivotal role in cardiac remodelling during viral-induced inflam-
mation13 and myocardial infarction14. In general, they can be divided into two main subsets identified by the 
expression of Ly6C. Pro-inflammatory monocytes are Ly6Chigh expressing cells, whereas their anti-inflammatory 
and reparative counterparts are characterized by Ly6Clow expression. The chemokines CCL2 and CCL7 medi-
ate Ly6Chigh monocyte recruitment, whereas Cx3CL1 governs Ly6Clow infiltration into the myocardium15. In 
Coxsackievirus B (CVB) 3-induced myocarditis, Müller and co-authors could demonstrate that ablation of 
CX3CR1 resulted in an increased level of CCL2 accompanied by higher numbers of monocytes/macrophages16, 
further indicating the relevance of the chemokines CCL2 and Cx3CL1 in the attraction of monocytes.
Based on the finding that IFN-γ counteracts TGF-ß1-induced cardiac fibrosis11 on the one hand, and the 
relevance of monocyte subpopulations during inflammation and wound healing on the other hand15, we sought 
to examine in vitro how IFN-γ can influence the chemokine profile of cardiac (myo)fibroblasts and subsequent 
attraction of pro-inflammatory versus anti-inflammatory monocytes.
Results
IFN-γ reduces TGF-ß1-induced collagen production and myofibroblast differentiation. Before 
evaluating the impact of IFN-γ on the TGF-β1-mediated chemokine response and subsequent effect on the 
attraction of monocyte subsets, the impact of TGF-β1 + IFN-γ on collagen production and myofibroblast differ-
entiation was determined. Confirming previous findings17, 24 h stimulation of cardiac fibroblasts with TGF-β1 
led to a 6.2-fold (p < 0.0001), 4.1-fold (p < 0.0001), 3.9-fold (p < 0.0001) and 6.1-fold (p < 0.0001) higher collagen 
1a1, collagen 3a1, TGF-ß1, and α-SMA mRNA expression as compared respectively to control cardiac fibroblasts, 
which is indicative for myofibroblast differentiation (Fig. 1A,B,E,F). Additional treatment with IFN-γ abrogated 
the TGF-ß1-mediated increase, leading to 3.8-fold (p < 0.001) and 2.6-fold (p < 0.001) lower collagen 3a1 and 
α-SMA mRNA expression levels 24 h post stimulation as compared respectively to sole TGF-β1-stimulated 
cardiac fibroblasts (Fig. 1B,F). On protein level, a 4.2-fold (p < 0.0001) increased expression of collagen I was 
observed in TGF-β1-treated cardiac fibroblasts versus control cardiac fibroblasts (Fig. 1C). In parallel, the amount 
of secreted collagen I in the cell culture supernatant was increased by 7.1-fold (p < 0.0001) after sole TGF-β1 
stimulation in comparison to control cardiac fibroblasts (Fig. 1D). Further evaluation of the collagen crosslinking 
enzymes Lox-1 and LoxL-2 demonstrated that TGF-ß1 induced Lox-1 and LoxL-2 gene expression versus control 
cardiac fibroblasts (Lox-1: 4.8-fold, p < 0.0001; LoxL-2: 6.1-fold, p < 0.0001) 24 h post stimulation (Fig. 1H,I).
Compared to sole TGF-ß1 stimulation, administration of TGF-ß1 + IFN-γ resulted in a 2.8-fold (p < 0.0001) 
decreased collagen I protein expression in cardiac fibroblasts and a 3.1-fold (p < 0.0001) reduced collagen I 
amount in cell culture supernatant (Fig. 1C,D). Immunofluorescence staining further showed a significant 
reduction of α-SMA protein expression after treatment with both stimuli compared to single TGF-ß1 treatment 
(Fig. 1G). With respect to Lox-1 and LoxL-2 expression, 24 h co-stimulation with TGF-ß1 + IFN-γ led to 1.6-fold 
(p < 0.05) and 2.8-fold (p < 0.05) lower Lox-1 and LoxL-2 mRNA levels as compared respectively to sole TGF-ß1 
administration (Fig. 1H,I).
IFN-γ induces an inflammatory phenotype in cardiac fibroblasts. Before assessing the impact of 
TGF-ß1, IFN-γ, and TGF-ß1 + IFN-γ stimulation on cardiac fibroblast chemokine expression, we evaluated how 
these stimuli could affect the cardiac fibroblasts as inflammatory supporter cells in terms of cytokine and adhesion 
molecule expression (Fig. 2). Therefore, gene expression of tumor necrosis factor (TNF)-α, interleukin (IL)-6, 
intercellular adhesion molecule (ICAM)-1 and vascular adhesion molecule (VCAM)-1 was measured. TGF-ß1 
treatment alone led to a 3.0-fold (p < 0.05) and 39.6-fold (p < 0.0001) increase in TNF-α and IL-6 mRNA expres-
sion versus control fibroblasts after 24 h (Fig. 2A,B), respectively, whereas no significant change in the expression 
of ICAM-1 and VCAM-1 was detected (Fig. 2C,D). Interestingly, simultaneous treatment with TGF-ß1 + IFN-γ 
caused a 3.7-fold (p < 0.0001) and 2.3-fold (p < 0.001) induction of ICAM-1 and VCAM-1 mRNA in comparison 
to TGF-β1 alone (Fig. 2C,D). Furthermore, TGF-ß1 + IFN-γ boosted the increased expression of TNF-α, as indi-
cated by a 4.2-fold (p < 0.0001) elevation compared to TGF-β1 administration.
IFN-γ further modulates chemokine expression in TGF-ß1 stimulated fibroblasts. In view of 
getting in vitro insights in whether TGF-ß1 and IFN-γ influence the attraction of immune cells towards the heart 
during the remodelling process, chemokine production upon TGF-ß1, IFN-γ, and TGF-ß1 + IFN-γ stimula-
tion of C4 fibroblasts and cardiac fibroblasts was examined (Fig. 3). In supernatants of C4 fibroblasts, 1.4-fold 
(p < 0.01), 1.4-fold (p < 0.01) and 1.7-fold (p < 0.0001) elevated CCL2, CCL7 and Cx3CL1 protein levels were 
observed after TGF-ß1 stimulation as compared respectively to control C4 fibroblasts (Fig. 3A–C). Interestingly, 
the addition of IFN-γ to TGF-ß1 further increased the secretion of CCL2, CCL7, and Cx3CL1 versus sole TGF-ß1 
treatment (CCL2: 1.6-fold, p < 0.0001; CCL7: 2.2-fold, p < 0.0001; Cx3CL1: 1.5-fold, p < 0.0001). In accord-
ance with the obtained results for C4 fibroblasts, cardiac fibroblasts also altered their chemokine release due 
to cytokine stimulation by 2.4-fold (p < 0.0001), 2.5-fold (p < 0.0001) and 2.9-fold (p < 0.0001) higher CCL2, 
CCL7, and Cx3CL1 protein levels upon TGF-ß1 + IFN-γ co-stimulation in comparison to sole TGF-ß1 treatment 
(Fig. 3F–H), respectively.
Since CCL2 and CCL7 are chemokines attracting pro-inflammatory monocytes and Cx3CL1 attracts 
anti-inflammatory monocytes15, we next calculated the ratio of CCL2 towards Cx3CL1 and CCL7 towards 
Cx3CL1 as indicative parameters of monocyte subset migration. In C4 fibroblasts, sole TGF-ß1 stimulation led 
to a 1.3-fold (p < 0.001) and 1.3-fold (p < 0.05) lower CCL2/Cx3CL1, and CCL7/Cx3CL1 ratio as compared 
respectively to the control fibroblasts (Fig. 3D,E), whereas addition of IFN-γ resulted in a 1.4-fold (p < 0.01) 
higher CCL7/Cx3CL1 ratio versus single TGF-ß1 treatment (Fig. 3D). No difference in CCL2/Cx3CL1 ratio 
was observed between supernatants of TGF-ß1 + IFN-γ and sole TGF-ß1-treated C4 fibroblasts (Fig. 3C). A 
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similar regulation in CCL2/Cx3CL1 and CCL7/Cx3CL1 ratio was found for the supernatants of TGF-ß1- and/or 
IFN-γ-stimulated cardiac fibroblasts (Fig. 3I,J).
IFN-γ reduces TGF-ß1-induced expression and activity of matrix metalloproteinase (MMP)-2. 
Given the relevance of MMP-2 on CCL7 cleavage18, we next analyzed the effects of TGF-ß1, IFN-γ, and 
TGF-ß1 + IFN-γ on the expression and activity of MMP-2 (Fig. 4). First, we evaluated their impact on CCL7 
mRNA expression and confirmed the observed regulation of CCL7 on protein level. In detail, TGF-ß1 treatment 
Figure 1. IFN-γ reduces TGF-ß1-induced transdifferentiation of cardiac fibroblasts. Data show the gene 
expression of the extracellular matrix proteins Col1a1 (A) and Col3a1 (B) and myofibroblast markers TGF-
ß1 (E) and α-SMA (F) after 6 and 24 h incubation with or without TGF-ß1 and/or IFN-γ. Additionally, 
representative western blots (C,D) and quantification of Collagen I in cell lysate (C) or supernatant (D) after 
72 h stimulation are depicted. (G) α-SMA marked by a Cy3-conjugated streptavidin antibody (red) and DAPI 
for nuclear staining (blue). Recording of the images was done in a 100× magnification (scale bar = 100 μm). To 
characterize collagen crosslinking, the gene expression of the crosslinking enzymes (H) Lox-1 and (I) LoxL-2 
were measured. Bar graphs represent the mean ± SEM of 3 independent experiments after normalization to the 
corresponding control fibroblasts. Statistical analysis was performed by One way-ANOVA or Kruskal Wallis test 
(#p < 0.05 vs co, *p < 0.05 vs TGF-β1, §p < 0.05 vs IFN-γ).
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for 24 h resulted in a 4.6-fold (p < 0.01) higher CCL7 mRNA level compared to control fibroblasts (Fig. 4A). The 
combined stimulation with TGF-ß1 + IFN-γ led to a 2.7-fold (p < 0.001) enhanced CCL7 expression level versus 
single TGF-ß1 administration.
In parallel, MMP-2 expression was 1.7-fold (p < 0.0001) induced after sole TGF-ß1 administration com-
pared to control fibroblasts (Fig. 4B), whereas addition of IFN-γ to TGF-ß1 diminished MMP-2 mRNA lev-
els by 2.0-fold (p < 0.0001). In line with the increased gene expression, proMMP-2 and MMP-2 activity were 
1.3-fold (p < 0.01) and 1.8-fold (p < 0.01) higher after TGF-ß1 stimulation versus control fibroblasts (Fig. 4D,E), 
respectively. In comparison to TGF-ß1, proMMP-2 and MMP-2 activity was 1.4-fold (p < 0.0001) and 1.6-fold 
(p < 0.01) suppressed by the simultaneous stimulation with TGF-ß1 + IFN-γ, respectively.
IFN-γ in combination with TGF-β1 induces migration of pro-inflammatory monocytes. To ver-
ify how the different CCL2, CCL7, and Cx3CL1 chemokine expression affects the attraction of different monocyte 
subsets, a migration assay was performed with splenocytes from control C57BL6/j mice towards the supernatants 
of TGF-ß1- and/or IFN-γ-stimulated C4 fibroblasts and cardiac fibroblasts (Fig. 5). The lower CCL2/Cx3CL1 
and CCL7/Cx3CL1 ratio in the supernatant of TGF-ß1-stimulated versus control C4 fibroblasts was paralleled 
by a 1.1-fold (p < 0.05) higher ratio of Ly6Clow towards Ly6Chigh migrated cells, indicating a lower number of 
attracted pro-inflammatory Ly6Chigh monocytes compared to anti-inflammatory Ly6Clow monocytes (Fig. 5A). 
In contrast, the ratio of Ly6Clow/Ly6Chigh migrated monocytes was 1.3-fold (p < 0.0001) lower versus the super-
natant of TGF-ß1 + IFN-γ- compared to TGF-ß1-stimulated fibroblasts. In agreement to the observed results 
for C4 fibroblasts, supernatant of TGF-β1-stimulated cardiac fibroblasts also attracted more Ly6Clow monocytes 
than Ly6Chigh monocytes (Fig. 5B), whereas TGF-β1 + IFN-γ conditioned media mainly induced the migration 
of Ly6Chigh monocytes.
Discussion
The prominent findings of the present study are that TGF-ß1 induces the production of CCL2, CCL7, and 
Cx3CL1 in cardiac fibroblasts, which results in an enhanced migration of (anti-inflammatory) Ly6Clow mono-
cytes. IFN-γ combined with TGF-ß1 induces a chemokine profile in cardiac fibroblasts in favor of attracting 
pro-inflammatory monocytes, as indicated by a reduction of the Ly6Clow/Ly6Chigh monocyte ratio.
Myocardial remodelling is a complex process, which involves multiple different steps19. After an initial damage 
to the heart, the immune system is activated and coordinates the function of several cell types, both of immune 
and non-immune origin, thereby affecting the pathological remodelling of the heart and the progression to heart 
Figure 2. IFN-γ modulates TGF-ß1-induced cytokine and adhesion molecule expression of cardiac fibroblasts. 
To determine the inflammatory phenotype after stimulation with TGF-ß1, IFN-γ, or both, the mRNA 
expression of (A) TNF-α, (B) IL-6, (C) ICAM-1, and (D) VCAM-1 was investigated. Bar graphs represent 
the mean ± SEM of 3 independent experiments after normalization to the corresponding control fibroblasts. 
Statistical analysis was performed by One way-ANOVA or Kruskal Wallis test (#p < 0.05 vs co, *p < 0.05 vs 
TGF-β1, §p < 0.05 vs IFN-γ).
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failure2. In patients with chronic heart failure, serum levels of pro-inflammatory cytokines and chemokines are 
upregulated and correlate with the severity of the disease and the prognosis20,21. We previously demonstrated 
that IFN-γ decreases the differentiation of fibroblasts from the infarcted area in a mouse model of myocardial 
infarction, leading to decreased production of collagen I and III and impaired wound healing11. Based on this 
finding, we wanted to further explore the impact of IFN-γ on TGF-ß1-induced chemokine expression of cardiac 
fibroblasts and their subsequent potential of attracting monocyte subsets.
Cardiac fibroblasts get activated in the myocardium mainly by pro-fibrotic factors such as TGF-β122 and dif-
ferentiate into myofibroblasts, which are characterized by high expression of α-SMA, increased production of 
extracellular matrix proteins, mainly collagens2, and upregulated expression of the crosslinking enzymes Lox-1 
and LoxL-2, which on their turn promote fibroblast-to-myofibroblast activation23–25. In accordance with previ-
ous reports showing anti-fibrotic effects of IFN-γ26–28, we demonstrate that simultaneous stimulation of cardiac 
fibroblasts with TGF-β1 and IFN-γ resulted in lower gene and protein expression of collagens and α-SMA, and 
led to lower expression levels of Lox-1 as well as LoxL-2. Interestingly, Lox-1 is besides its role in crosslinking 
also known to resolve inflammation by reducing CCL2 expression29. In accordance to this negative correlation 
Figure 3. IFN-γ- and TGF-ß1-induced chemokine secretion and -modulated CCL2/Cx3CL1 and CCL2/
Cx3CL1 protein ratio. (A–C) Protein levels of CCL2 (pg/ml), CCL7 (pg/ml), and Cx3CL1 (ng/ml) and (D,E) 
corresponding CCL2/Cx3CL1 and CCL2/Cx3CL ratio’s of control, TGF-ß1-, IFN-γ-, or TGF-β1 + IFN-γ-
stimulated C4 fibroblasts after 72 h incubation time. In agreement, changes in secreted (F) CCL2 (pg/ml), 
(G) CCL7 (pg/ml) and (H) Cx3CL1 (ng/ml) and (I,J) CCL2/Cx3CL1 and CCL2/Cx3CL ratio’s from control, 
TGF-ß1-, IFN-γ-, or TGF-β1 + IFN-γ-stimulated cardiac fibroblasts were observed. Data are depicted as 
mean ± SEM from 3 independent experiments. Statistical analysis was performed by One way-ANOVA or 
Kruskal Wallis test (#p < 0.05 vs co, *p < 0.05 vs TGF-β1, §p < 0.05 vs IFN-γ).
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between Lox-1 and CCL2, higher CCL2 levels were observed in the conditioned media of TGF-ß1 + IFN-γ- ver-
sus sole TGF-ß1-stimulated cardiac fibroblasts. However, Lox-1 also has own chemoattractant potential30. This 
hints to the complex role of Lox in inflammation and monocyte attraction on the one hand, and further confirms 
cardiac fibroblasts as inflammatory supporter cells on the other hand2,3. Further investigations are needed to 
clarify the specific role of cardiac fibroblast-derived Lox-1 and/or LoxL-2 in the attraction of monocyte (subsets).
Besides CCL2, also CCL7 and Cx3CL1 levels were enriched in cell culture supernatant of TGF-ß1-stimulated 
cardiac fibroblasts compared to control fibroblasts. Since MMP-2 is known to degrade CCL731, we evaluated 
whether the found CCL7 protein expression could be explained by changes in MMP-2 activity. Conforming 
Westermann et al.22, who demonstrated an increase in MMP-2 activity upon TGF-ß1 stimulation of cardiac 
fibroblasts derived from endomyocardial biopsies of HFpEF patients, TGF-ß1 increased MMP-2 expression 
and activity. In contrast to that, co-stimulation of TGF-ß1 with IFN-γ reduced MMP-2 expression and activity, 
which might explain the higher CCL7 expression under these stimuli versus TGF-ß1 stimulation. This finding 
is in line with the observation that reduced MMP-2 activity in viral-induced myocarditis was associated with 
increased levels of CCL7/MCP-3 and translated in exacerbation of cardiac immune cell infiltration32. In addition, 
we demonstrated that TGF-ß1 + IFN-γ further promotes an inflammatory phenotype of cardiac fibroblasts, as 
indicated by higher expression of the cell adhesion molecules ICAM-1 and VCAM-1, and of the inflammatory 
cytokine TNF-α compared to sole TGF-ß1 supplementation.
Figure 4. IFN-γ reduces TGF-ß1-induced expression and activity of MMP-2 in cardiac fibroblasts. Gene 
expression of CCL7 (A) and MMP-2 (B) after 6 and 24 h incubation time. To investigate the MMP-2 activity, 
zymography (C) of the cell culture supernatant was performed followed by quantification of proMMP-2 (D) and 
MMP-2 (E). Data are depicted as mean ± SEM from 3 independent experiments. Statistical analysis was performed 
by One way-ANOVA or Kruskal Wallis test (#p < 0.05 vs co, *p < 0.05 vs TGF-β1, §p < 0.05 vs IFN-γ).
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Regarding cell migration, TGF-ß1-stimulated cardiac fibroblasts exhibited lower CCL2/Cx3CL1 and CCL7/
Cx3CL1 ratios in their conditioned media compared to control fibroblasts. In accordance to the chemoattractant 
potential of CCL2 and CCL7 attracting pro-inflammatory Ly6Chigh monocytes, whereas Cx3CL1 mainly attracts 
Figure 5. IFN-γ- and TGF-ß1-induced monocyte migration. (A) Flow cytometry analysis of CD11b+CD115+Ly6C+ 
stained cells shows differences between the ratios of Ly6Clow/Ly6Chigh monocytes versus the different conditioned 
media in C4 fibroblasts. (B) Indication for enhanced migration of Ly6Clow monocytes towards TGF-ß1-conditioned 
media of cardiac fibroblasts, whereas co-stimulation with TGF-β1 + IFN-γ increases the number of migrated Ly6Chigh 
monocytes. (C) Gating strategy to define the amount of CD11b+CD115+Ly6C+ cells. (D) Representative dot blots 
for the migrated monocytes of the different conditioned media of stimulated C4 fibroblasts (n = 6/condition). 
(E) Representative dot blots for the migrated monocytes of the different conditioned media of stimulated cardiac 
fibroblasts (n = 3/condition). Data are shown as ratio of Ly6Clow/Ly6Chigh monocytes of 3 independent experiments. 
Statistical analysis was performed by One way-ANOVA or Kruskal Wallis test (#p < 0.05 vs co, *p < 0.05 vs TGF-β1, 
§p < 0.05 vs IFN-γ).
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anti-inflammatory Ly6Clow monocytes15,33, this TGF-ß1-induced chemokine profile was reflected in the attrac-
tion of a higher number of anti-inflammatory Ly6Clow cells compared to pro-inflammatory Ly6Chigh monocytes. 
Simultaneous stimulation with TGF-ß1 and IFN-γ promoted the pro-inflammatory phenotype, as shown by the 
higher ratio of CCL7/Cx3CL1 compared to sole TGF-ß1 treatment. This was reflected in the enhanced migration 
of pro-inflammatory Ly6Chigh monocytes towards this media. Similar results were observed for rat cardiac fibro-
blasts by which TGF-β1 conditioned media induced M2 macrophage polarization, whereas LPS-treated media 
favored M1 macrophage polarization34. These findings are further conforming own data from previous experi-
mental CVB3-induced myocarditis mice, which exhibited elevated CCL2/Cx3CL1 and CCL7/Cx3CL1 ratios, and 
were associated with an increased cardiac presence of pro-inflammatory towards anti-inflammatory monocytes13. 
Finally, the TGF-ß1- and IFN-γ-induced chemokine profile of cardiac fibroblasts and subsequent attraction of 
pro- and anti-inflammatory monocytes corresponds to the sequential attraction of Ly6Chigh and Ly6Clow mono-
cytes post myocardial infarction15 and their function in cardiac wound healing and scar formation33,35.
In conclusion, TGF-ß1 boosts chemokine expression stimulating the attraction of Ly6Clow monocytes, whereas 
IFN-γ in conjunction with TGF-ß1, particularly attracts Ly6Chigh monocytes (Fig. 6). It is tempting to speculate 
that primed fibroblasts contribute to the repair process via attracting specific monocytes subsets, and that this 
homing is regulated via a balance between pro-inflammatory (IFN-γ) versus pro-fibrotic (TGF-ß1) factors. It is 
clear that during the pathogenesis of heart failure more cytokines and growth factors are involved in the cardiac 
remodelling process than the pro-inflammatory IFN-γ and the pro-fibrotic TGF-ß1. Nevertheless, this study is 
the first study to our knowledge, which points out the interplay among IFN-γ and TGF-ß1 on cardiac fibroblasts 
influencing the functional phenotype of the (myo)fibroblasts with respect to the attraction of monocyte subsets. 
However, further studies are warranted to get further insights into the complex regulation of fibroblasts in the 
inflammatory and remodelling process of distinct cardiac disorders.
Materials and Methods
Isolation and expansion of cardiac fibroblasts. Murine cardiac fibroblasts were obtained from the LV 
of 8–12 weeks old healthy male C57BL6/j mice (n = 6, Charles River, Sulzfeld, Germany), cut in approximately 
2 mm large pieces and fixed in 12-well culture plates (n = 1/well). Therefore, mice were euthanized via cervical 
dislocation, which is approved by the local ethics committee (Landesamt für Gesundheit und Soziales, Berlin, 
T0098/11) and in accordance to the European legislation for the Care and Use of Laboratory Animals (Directive 
2010/63/EU). The outgrowing cardiac fibroblasts were cultured in Dulbecco’s modified eagle medium (DMEM; 
PAA, Cölbe; Germany) containing 20% fetal calf serum (FCS; Biochrom, Berlin, Germany), 100 U/mL penicillin 
and 100 µg/mL streptomycin (both PAA, Cölbe, Germany) at 37 °C with 95% air and 5% CO2. Stimulation exper-
iments were performed with cells in passage 4 to 8.
Figure 6. Hypothetical scheme representing how TGF-ß1 and IFN-γ affect the chemokine expression and 
subsequent monocyte migration of cardiac fibroblasts. The Figure illustrates the transdifferentiation process of 
fibroblasts towards myofibroblasts under TGF-ß1 and TGF-ß1 + IFN-γ conditions. Depending on the stimulus, 
the specific chemokine profile (CCL2, CCL7, and Cx3CL1) of the myofibroblasts results in a more pronounced 
attraction of Ly6Clow monocytes (TGF-ß1 stimulation) or of Ly6Chigh monocytes (TGF-ß1 + IFN-γ stimulation). 
The Figure uses elements previously published by Van Linthout et al.2  Stands for Ly6C.
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Culture and stimulation of C4 fibroblasts. Murine C4 fibroblasts, a murine fibroblast cell line derived 
from embryonic BALB/c mice by SV40 infection in vitro36, were cultured in Iscove medium (Sigma Aldrich, 
Munich, Germany) supplemented with 10% FCS (Biochrom) and 1% penicillin/streptomycin (Biochrom). For 
stimulation experiments, 60,000 cells/well were plated in 12-well-plates. One day after plating, cells were washed 
once with phosphate buffered saline (PBS; Thermo Fisher Scientific, Waltham, Massachusetts, USA), and starva-
tion medium (Iscove medium + 0.05% FBS + 1% P/S) was added. After 24 hours (h), cells were stimulated with 
or without 5 ng/mL TGF-β1 (Peprotech, Hamburg, Germany), 10 ng/mL IFN-γ (Peprotech) or both in starvation 
medium. 72 h after stimulation, the supernatant was harvested, centrifuged (10 minutes (min) at 4 °C, 12000 × g) 
and aliquoted to further investigate chemokine secretion and perform chemotaxis assays.
Stimulation experiments of cardiac fibroblasts. For stimulation experiments, murine cardiac fibro-
blasts were seeded out in 24-well culture plates (30,000 cells/well) for RNA isolation and immunofluorescence 
or 12-well culture plates (10,000 cells/well) for protein analysis and zymography. Stimulation with TGF-β1 
(Peprotech) was chosen to induce differentiation of cardiac fibroblasts into myofibroblasts, mimicking the envi-
ronment present during cardiac remodelling37. When reaching 80% confluence, cells were serum starved in 
DMEM (PAA) containing 0.5% FCS (Biochrom), 100 U/mL penicillin and 100 µg/mL streptomycin (both PAA), 
overnight. After washing once with PBS (PAA), cells were incubated with IFN-γ (Peprotech) at a final concentra-
tion of 10 ng/mL or with 5 ng/mL TGF-β1 or both up to 72 h. Unstimulated control cells were incubated for the 
same time period with serum-starved DMEM (PAA). Stimulation experiments were carried out with n = 6 wells 
per stimulation condition and repeated three times.
RNA Isolation, cDNA transcription and real-time-PCR. After 6 and 24 h incubation, cells were washed 
once with PBS (PAA). RLT-Buffer containing 1% β-mercaptoethanol was added and cell lysates were stored at 
−80 °C until further investigations. After thawing, 70% ethanol was added and RNA was isolated using the RNeasy 
kit (Qiagen, Hilden, Germany). Next, 250 ng of total RNA was reverse transcribed to cDNA with the high-capacity 
kit (Applied Biosystems, Darmstadt, Germany). Gene expression analysis was performed within the ViiA7 TaqMan 
System (Life technologies, Darmstadt, Germany) by using 5 μL of the gene expression master mix (Applied 
Biosystems), 0.5 μL of the gene expression assay (Applied Biosystems) and 1 μL of the cDNA in a final volume of 
10 μL. Following gene expression assays were used: Col1a1 (Mm01302043_g1), Col3a1 (Mm00802331_m1), α-SMA 
(Mm00725412_s1), TGF-β1 (Mm00441724_m1). Lox-1 (Mm00495386_m1), LoxL-2 (Mm00804740_m1), MMP-2 
(Mm00439505_m1), CCL7 (Mm00443113_m1), ICAM-1 (Mm01320970_m1), VCAM-1 (Mm00516023_m1), 
TNF-α (Mm00443258_m1) and IL-6 (Mm00446190_m1). For the quantification of the relative mRNA expression, 
all data were normalized to CDKN1b (Mm00438167_g1) as an internal control expressed in the 2−ΔCt formula. For 
comparison of the different response to TGF-β1 and IFN-γ treatment, mRNA data are expressed as 2−ΔΔCt by nor-
malization to the corresponding untreated control.
Immunofluorescence staining. Murine cardiac fibroblasts were incubated with external stimuli for 
up to 72 h. After washing once with PBS (PAA), cells were fixed with 4% paraformaldehyde for 10 min. Cells 
were permeabilized with Triton X-100 and incubated with avidin blocking solution for 30 min. Then, cells were 
treated with the primary antibody α-SMA (1:50; Dako, Hamburg, Germany) in the presence of biotin solution 
for 90 min. Afterwards, fibroblasts were washed twice followed by 1 h incubation with the biotinylated secondary 
antibody (1:250; Dianova, Hamburg, Germany). As described previously11, cells were finally incubated 30 min 
with Cy3-conjugated streptavidin (1:250; Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA) 
for fluorescence visualization and with Diamidinphenylindol (DAPI; 1:100; Invitrogen, Darmstadt, Germany) as 
nuclear staining. All incubations were performed at room temperature.
Protein extraction and western blot analysis. After 72 h incubation time, supernatants were collected 
and cells were washed with PBS. Then, fibroblasts were lysed with 150 µL cell lysis buffer containing a protease 
and phosphatase inhibitor cocktail (both Sigma-Aldrich). Denaturized proteins were electrophoresed on 10% 
SDS-polyacrylamide gels, followed by transfer onto PVDF membranes and blocking with 5% skim milk for 
30 min at room temperature. Blots were incubated over night with primary antibodies against collagen I (1:1000; 
Merck Millipore, Darmstadt, Germany) or GAPDH (1:1000; Cell Signaling, Frankfurt am Main, Germany) at 
4 °C. The bound antibodies were detected by the respective horseradish peroxidase-conjugated secondary anti-
bodies (1:2500, Cell signaling), which were visualized with super signal solution (Thermo Scientific, Darmstadt, 
Germany). The resulted chemiluminescence was measured by using the Chemo Star Imager camera system 
(INTAS Science Imaging Instruments, Göttingen, Germany). The relevant blots were analyzed by ImageJ soft-
ware (NIH, Maryland, USA). For quantification of the protein levels, GAPDH was used as an internal control for 
each sample.
Zymography. Gelatin zymography from cell culture supernatant of stimulated cardiac fibroblasts was 
performed to determine the gelatinolytic activities of MMP-2 in response to TGF-β1 and IFN-γ. After 72 h 
incubation, supernatants were collected and mixed with 5× sample buffer. Samples were loaded on 10% 
SDS-polyacrylamide gels copolymerized with 1 mg/mL of gelatine (VWR, Darmstadt, Germany). Following 
electrophoresis, gels were washed in renaturing buffer with gentle shaking for 20 min. Digestion of gelatine was 
carried out twice in developing buffer, at first for 20 min at room temperature and then for 18 h at 37 °C. Next, 
the solution was replaced and gels were incubated again with cold developing buffer for 20 min. After develop-
ment, gels were stained with 0.5% coomassie G250 blue solution (Sigma-Aldrich) and finally slowly destained 
with destain solution. Recording of images was carried out under UV light using the BioDoc 2.0 Imaging system 
(UVP, Cambridge, UK). ImageJ (NIH) was used for quantification of the bands and expressed as n-fold to the 
corresponding control.
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ELISA. To determine the secreted amount of CCL2 and CCL7 in the cell culture media of stimulated cells, 
the respective ELISA kits (both Peprotech) were used. In brief, ELISA microplates were coated overnight with 
the capture antibody (1:100) followed by 4 times washing with PBS + 0.05% Tween 20, and blocking with the 
blocking buffer for at least 1 h. Next, standards or samples were added to the wells for 2 h, followed by washing 
and incubation with the detection antibody (1:200) for additional 2 h. After washing, the avidin-HRP conjugate 
(1:2000) was added to each well. For color development, ABTS liquid substrate (Sigma-Aldrich) was used and the 
absorbance was measured at 405 nm. To determine the secreted amount of Cx3CL1, the murine Cx3CL1 ELISA 
kit (Abcam, Cambrigde, UK) was used. The absorbance was measured at the announced wavelength according 
to the manufacturer’s protocol.
CytoSelect™ cell migration assay. To determine the chemotactic potential of the supernatants of the 
(un)stimulated fibroblasts, a cell migration assay (Cell Biolabs, San Diego, USA) was performed according to the 
manufacturer’s protocol. Therefore, splenocytes of 8–12 weeks old healthy male C57BL6/j mice (n = 10, Charles 
River) were isolated, pooled and placed at a density of 0.1 × 106 cells/ml on the upper membrane chamber. Under 
sterile conditions, 150 µL of the respective supernatants (=further named as conditioned media) were added 
to the wells of the feeder tray to explore chemotaxis. After 24 h incubation time, migratory cells were harvested 
and further analyzed by flow cytometry. For migration experiments versus conditioned media of C4 fibroblasts, 
migrated splenocytes of 8 wells/condition were pooled to obtain enough cells for subsequent flow cytometry. The 
migration assay was repeated 6 times/condition (n = 6). With respect to cardiac fibroblasts, migrated splenocytes 
of 4 wells/condition were pooled and performed three times (n = 3).
Flow cytometry. To investigate the different monocyte subsets within the migrated splenocytes, flow cytom-
etry was performed. In general, cells were first washed with PBS and after centrifugation stained at 4 °C and 
30 min for CD11b (2:5), CD115 (1:50) and Ly6C (1:20) to determine the fraction of migrated pro-inflammatory 
(CD11b+CD115+Ly6Chigh) and patrolling/reparative (CD11b+CD115+Ly6Clow) monocytes. Antibodies against 
CD11b, CD115 and Ly6C were purchased from Biolegend (London, UK). Sample analysis was performed using 
the MACSQuant Analyzer (Miltenyi Biotec, Bergisch Gladbach, Germany) and flow cytometry data were ana-
lyzed with FlowJo 8.7. software (FlowJo, LLC, RO, USA).
Statistical analysis. Data are shown as mean ± SEM and all statistical analyses were performed using 
GraphPad Prism 7.0 software (GraphPad Software Inc, La Jolla, USA). First, data were tested with Shapiro-Wilk 
test for normal distribution. For the comparison of the different stimuli, parametric data were tested with ordi-
nary One-way-ANOVA (Fisher’s LSD post hoc test) or with Kruskal-Wallis test (uncorrected Dunn’s post hoc 
test) in case of non-parametric data sets. Statistical differences were assessed significant at p < 0.05.
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